AV608

DRUG3 trials

Sponsors

Avera Pharmaceuticals

Conditions

Irritable Bowel Syndrome (IBS)Overactive Bladder SyndromeSocial Phobia

Phase 1

Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome

TerminatedNCT00316550

Avera PharmaceuticalsIrritable Bowel Syndrome (IBS)

Start: 2006-04-30End: 2007-09-30Target: 24Updated: 2008-02-25

Phase 2

Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder

CompletedNCT00294346

Avera PharmaceuticalsSocial Phobia

Start: 2006-02-28End: 2006-12-31Target: 180Updated: 2008-02-25

Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity

TerminatedNCT00335660

Avera PharmaceuticalsOveractive Bladder Syndrome

Start: 2006-06-30End: 2007-09-30Target: 62Updated: 2008-02-25